INTRODUCTION: Rheumatic heart disease (RHD) poses a substantial global health challenge, especially impacting resource-limited nations, with over 40.5 million cases reported in 2019. The crucial role of Benzathine penicillin G in both primary and secondary prevention, particularly the latter, emphasizes its significance. METHOD: Following PRISMA guidelines, our systematic review explored Medline, Scopus, Google Scholar, and Embase databases from 1990 to 2022. Registered with PROSPERO ), the review utilized quality appraisal tools, including the PRISMA checklist, Cochrane bias tool and Newcastle-Ottawa scale. The objective was to identify and stratify the impact of socio-economic factors on adherence to secondary prophylaxis in RHD. RESULTS AND DISCUSSION: The impact of education on adherence has been found to be significant. Socially disadvantaged environments significantly influenced adherence, shaped by education, socio-economic status, and geographical location and access to healthcare. Surprisingly, lower education levels were associated with better adherence in certain cases. Factors contributing to decreased adherence included forgetfulness, injection-related fears, and healthcare provider-related issues. Conversely, higher adherence correlated with younger age, latent disease onset, increased healthcare resources, and easy access. CONCLUSION: Patient education and awareness were crucial for improving adherence. Structured frameworks, community initiatives, and outreach healthcare programs were identified as essential in overcoming barriers to secondary prophylaxis. Taking active steps to address obstacles like long-distance commute, waiting time, injection fears, and financial issues has the potential to greatly improve adherence. This, in turn, can lead to a more effective prevention of complications associated with RHD.

Charles University 1st Faculty of Medicine Prague Czechia

KIST Medical College and Teaching Hospital Imadol

National Medical College and Teaching Hospital Birgunj Nepal

Provincial Hospital Madhesh Institute of Health Sciences Janakpur

Saint Vincent Hospital Worcester MA USA

Tribhuvan University Institute of Medicine Maharajgunj

Zobrazit více v PubMed

Ruan R, Liu X, Zhang Y, et al. . Global, Regional, and National Advances toward the Management of Rheumatic Heart Disease Based on the Global Burden of Disease Study 2019. J Am Heart Assoc. 2023;12:e028921. PubMed PMC

Beaton A, Okello E, Rwebembera J, et al. . Secondary antibiotic prophylaxis for latent rheumatic heart disease. N Engl J Med 2022;386:230–240. PubMed

Beaton A, Okello E, Rwebembera J, et al. . ADHERENCE TO SECONDARY PROPHYLAXIS OF RHEUMATIC FEVER IN PATIENTS WITH RHEUMATIC HEART DISEASE IN RURAL AREAS. Pak Heart J 51(3). doi:10.47144/phj.v51i3.1538 DOI

Nemani L, Maddury J, Barik R, et al. . A Cross-sectional study to look at the determinants of poor adherence to secondary penicillin prophylaxis for rheumatic heart disease at a tertiary care center in South India. J Clin Prev Cardiol 2018;7:5.

Thompson SB, Brown CH, Edwards AM, et al. . Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica. Pathog Glob Health. 2014;108:229–234. PubMed PMC

Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. PubMed PMC

Kang K, Chau KWT, Howell E, et al. . The temporospatial epidemiology of rheumatic heart disease in Far North Queensland, tropical Australia 1997–2017; impact of socioeconomic status on disease burden, severity and access to care. PLoS Negl Trop Dis 2021;15:e0008990. PubMed PMC

Kevat PM, Gunnarsson R, Reeves BM, et al. . Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever. J Paediatr Child Health 2021;57:419–424. PubMed PMC

Mekonen KK, Yismaw MB, Abiye AA, et al. . Adherence to Benzathine Penicillin G secondary prophylaxis and its determinants in patients with rheumatic heart disease at a cardiac center of an Ethiopian Tertiary Care Teaching Hospital. Patient Prefer Adherence 2020;14:343–352. PubMed PMC

Prasad A, Prasad A, Singh BK, et al. . Compliance to the secondary prophylaxis and awareness of rheumatic heart disease: a cross-sectional study in low-income province of India. J Fam Med Prim Care 2020;9:1431–1435. PubMed PMC

Longenecker CT, Morris SR, Aliku TO, et al. . Rheumatic heart disease treatment cascade in Uganda. Circ Cardiovasc Qual Outcomes 2017;10:e004037. PubMed PMC

Gasse B, Baroux N, Rouchon B, et al. . Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study. BMC Public Health 2013;13:131. PubMed PMC

Iyengar SD, Grover A, Kumar R, et al. . A rheumatic fever and rheumatic heart disease control programme in a rural community of north India. Natl Med J India 1991;4:268–271. PubMed

Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev 2002;2002:CD002227. PubMed PMC

Bach JF, Chalons S, Forier E, et al. . 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet Lond Engl 1996;347:644–648. PubMed

Carapetis JR, Beaton A, Cunningham MW, et al. . Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primer 2016;2:15084. PubMed PMC

Watkins DA, Beaton AZ, Carapetis JR, et al. . Rheumatic heart disease worldwide. J Am Coll Cardiol 2018;72:1397–1416. PubMed

Günther G, Asmera J, Parry E. Death from rheumatic heart disease in rural Ethiopia. The Lancet 2006;367:391. PubMed